Head of Investor Relations
Celldex Therapeutics, Inc. (CLDX)Equibles does not estimate personal net worth.
Get an email with a short summary when Celldex Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get CLDX alertsSarah Cavanaugh is recorded as Head of Investor Relations at Celldex Therapeutics, Inc. (CLDX). Sarah Cavanaugh has spoken on 1 investor event across 1 company, most recently for Celldex Therapeutics, Inc. on April 14, 2026. Celldex Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Celldex Therapeutics, Inc. includes Anthony Marucci (CEO and Board Member), Anthony S. Marucci (CEO and Board Member), Harry H. Penner, Jr. (Chairman and Board Member) and 7 others.
“It's interesting to add to that when you look at the biology, tryptase is a marker of mass cell burden. And for these patients on study, at the end of study, if their disease is back, it's typically also milder in form.”
Proxy statement
Start not stated–present
Last confirmed April 25, 2024
Biotechnology · Healthcare
Head of Investor Relations
